Transcriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn’s Disease Patients

Figure 1

Haematoxylin and Eosin (H&E) staining of intestinal mucosa and mesenteric adipose tissues segments of a representative Crohn’s disease patient. (a) Intestinal mucosa of a normal control subject (IC Group). (b) Intestinal mucosa of CD patient (ICD Group), showing crypt distortion, ulcers, and inflammatory infiltrate. (c) Mesenteric adipose tissue of a normal control subject (AC Group). (d) Mesenteric adipose tissue of CD patient (ACD Group) revealing characteristic morphometric features, with reduced adipocyte size. Nuclear counterstaining: Mayer’s haematoxylin. Original magnification ×20.

(a)

(b)

(c)

(d)